Repros Therapeutics Inc Stock

Stocks

27/01/18	Repros Announces Negative Opinion From the EMA for Enclomiphene	GL
16/12/17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency	GL
13/12/17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout	BU
13/12/17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders	BU
12/12/17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc	GL

02/04/15	Apple : Les valeurs à suivre sur les marchés américains
02/04/15	USA-Les valeurs à suivre à Wall Street

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
REPROS THERAPEUTICS INC	-.--%	+0.74%	-	-	0
LONZA GROUP AG	+1.37%	+1.35%	-11.46%	-11.56%	43.58B
REVOLUTION MEDICINES, INC.	+4.02%	+7.79%	+294.33%	+536.67%	34.03B
IQVIA HOLDINGS INC.	-1.69%	-2.89%	+13.70%	-17.71%	29.77B
BEONE MEDICINES AG	+1.41%	-0.96%	-0.53%	+33.41%	29.82B
CELLTRION, INC.	+1.16%	+9.79%	+14.27%	+22.28%	25.42B
ASCENDIS PHARMA A/S	+2.40%	+8.49%	-	-	13.87B
MEDPACE HOLDINGS, INC.	+0.03%	+2.10%	+56.75%	+111.91%	13.35B
EUROFINS SCIENTIFIC SE	+0.35%	-2.03%	+3.85%	+3.41%	12.85B
IONIS PHARMACEUTICALS, INC.	+0.93%	+0.57%	+107.81%	+77.40%	12.22B
Average	+1.00%	+1.88%	+59.84%	+94.48%	23.88B
Weighted average by Cap.	+1.25%	+1.86%	+61.66%	+105.83%